A sample of the library

See the evidence, not the hype.

Pepacora grades every option by condition, across peptides, Rx and hormones, with current research, what patients and peers report, and the cautions that matter. Here is a public look. The full library of 23 conditions and 100 compounds is for licensed, approved clinics.

In the headlines

The six peptides an FDA panel backed for compounding.

Now under interim HHS enforcement discretion, pharmacies can compound these six on a valid prescription. All six are already in the Pepacora library, graded and cited.

BPC-157

Promotes angiogenesis

TB-500

Promotes cell migration

KPV

Inhibition of NF-kB activation, blocking inflammatory cascade

MOTS-c

Regulates nuclear gene expression, promoting cellular homeostasis.

Semax

Modulates neurotransmitter levels by increasing dopamine and serotonin availability

Epitalon

Synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly) that upregulates hTERT/telomerase to elongate telomeres in normal somatic cells and epigenetically modulates neurogenic gene expression and circadian melatonin signaling.

How it reads one condition

Three kinds of evidence, in one view.

Condition Explorer · MCAS

Starting from the patient's presentation

Immune & Inflammation (primary)Tissue Repair (secondary)1 caution applies
Evidence · PubMedPreclinical

KPV, NF-κB pathway, does not trigger MRGPRX2 · PMID 19909746

Community · reportedPositive · 6 reports

Reduced flushing & GI flares

Peers · your network8 logged · 3 improved

At 12 weeks · real-world outcomes

LL-37, VIP, α-MSH flagged (MRGPRX2 degranulation). The engine applies it before you build.

For licensed clinicians

Open the full library.

Join the waitlist and, once access opens and your clinic is approved, explore every condition and compound, build protocols, prescribe under your NPI, and the pharmacy fills and ships to the patient.